Trial Profile
An International, Multicentre, Open Label Study To Assess The Effectiveness Of Amlodipine/Atorvastatin Combination In Subjects With Hypertension And Dyslipidaemia (The JEWEL II Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2021
Price :
$35
*
At a glance
- Drugs Amlodipine/atorvastatin (Primary)
- Indications Hyperlipidaemia; Hypertension
- Focus Therapeutic Use
- Acronyms JEWEL-II
- Sponsors Pfizer; Viatris Inc
- 26 Oct 2006 Status change
- 06 Nov 2005 New trial record.